Serono Discontinues Trial Programs
Serono announced the discontinuation of two phase 3 clinical trial programs; onercept (recombinant tumor necrosis factor binding protein) in moderate-to-severe…
Part of the
network
network
Tag: phase 3
Noven Announces MTS Trial Results
Noven Pharmaceuticals announced positive preliminary results from clinical trials of its methylphenidate transdermal system (MTS)...
Inspire Study Shows Mixed Findings
Inspire Pharmaceuticals announced results of a Phase 3 clinical study of diquafosol tetrasodium for treatment of dry eye.
